Ataxia-telangiectasia (A-T) is a rare human genetic disorder that is characterized by cancer predisposition, neurodegeneration, immunodeficiency, radiosensitivity, chromosomal instability and ...

Although HHT in Japanese patients had been reported as a case report or case series, there has been no large series so far. 1, 14 The purpose of this study is to describe the clinical presentations of ...

Macular telangiectasia (sometimes called idiopathic juxtafoveal telangiectasis or MacTel) is a disease that affects the macula. That's the part of your eye that allows you to see things directly in ...

IntraBio Inc., a global biopharmaceutical company focused on developing and commercializing therapies for neurological diseases, today announced that the U.S. Food and Drug Administration (FDA) has ...

Supported by phase 3 trial data showing significant SARA score improvements, levacetylleucine is on track to potentially become the first approved therapy for A-T.

Affecting the nervous system, immune system and other body organs, ataxia telangiectasia is characterized with uncoordinated movements of the individual suffering from this disorder. The secondary ...

AUSTIN, Texas--(BUSINESS WIRE)--IntraBio Inc. today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for levacetylleucine for the ...

IMMUNOLOGIC abnormalities, including hypogammaglobulinemia, abnormalities of gamma 1 A globulin, poor homograft rejection and structural abnormalities of the thymus gland, have recently been reported ...

Hereditary hemorrhagic telangiectasia, or Osler–Weber–Rendu syndrome, is an autosomal dominant vascular disorder that affects multiple systems. It is characterized by skin and mucosal telangiectasias ...

Benign hereditary telangiectasia (BHT) occurs when small thread veins have dilated and are visible on the skin and lips. On dark skin, these veins may appear purple. On light skin, they may look red.

Telangiectasias are small blood vessels that sit near the skin’s surface and widen and create visible patterns of lines. People often refer to them as spider veins. Telangiectasias may occur anywhere ...

FDA accepts sNDA for AQNEURSA® (levacetylleucine) for Ataxia-Telangiectasia — a rare, progressive neurodegenerative disease with no currently approved treatments Priority Review granted; PDUFA target ...